Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer.
about
TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor MilieuRelapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinityFusions of Tumor-derived Endothelial Cells with Dendritic Cells Induces Antitumor Immunity.CD8+ T-cell responses rapidly select for antigen-negative tumor cells in the prostate.Oncogene withdrawal engages the immune system to induce sustained cancer regression.An essential role for the immune system in the mechanism of tumor regression following targeted oncogene inactivation.Targeting c-MYC with T-cellsTrial Watch: Adoptive cell transfer immunotherapy.Functional expression cloning identifies COX-2 as a suppressor of antigen-specific cancer immunityFas expression by tumor stroma is required for cancer eradication.Noncanonical roles of the immune system in eliciting oncogene addictionPreventing tumor escape by targeting a post-proteasomal trimming independent epitope.Genetically engineered mouse models of cancer reveal new insights about the antitumor immune response.Spleen cells from young but not old immunized mice eradicate large established cancers.T cell immunotherapy for melanoma from bedside to bench to barn and back: how conceptual advances in experimental mouse models can be translated into clinical benefit for patients.Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance.Tumour ischaemia by interferon-γ resembles physiological blood vessel regression.Permissive expansion and homing of adoptively transferred T cells in tumor-bearing hosts.The immune system prevents recurrence of transplanted but not autochthonous antigenic tumors after oncogene inactivation therapy.Depot formation of doxycycline impairs Tet-regulated gene expression in vivo.Bladder cancer-associated cancer-testis antigen-derived long peptides encompassing both CTL and promiscuous HLA class II-restricted Th cell epitopes induced CD4+ T cells expressing converged T-cell receptor genes in vitro.
P2860
Q21131200-6EDCDD42-FB59-4D87-88B7-ABC1DF0E914EQ30413827-C928DD0F-492D-4F8B-8FA0-FEFC4544A1DEQ33594333-3D0E240E-32D0-419B-BAAF-3C4473FFA59DQ33931006-BEEE81D1-275D-4AA3-9867-5DB7033DF6A5Q33987633-FE963C57-F9D4-4D2C-82D7-92503D37F819Q34361976-466B402C-C0A5-4F2C-BBBE-A4DD92DCC25AQ35018846-6C7E1CDD-6E0C-4AB8-8A6C-6D1A9025ECBEQ36057432-23B8B63D-4F55-4CC5-AB44-347759701E7FQ36292012-EAE29B63-71B9-4387-BA77-BE010E724A3FQ36598412-7B177119-1E41-4954-AA65-D205E2EEF211Q36931816-D977464D-5F8C-4D70-9920-E86E6EAB7282Q37346707-0B8E16C5-ABD9-4320-953F-FDA95DEEBB7CQ37542092-E7E830B2-89FD-4459-B3B2-1DCCAED7453DQ37706396-230D8B70-9F4D-4DBF-9D07-B37CA3A41F9EQ38101679-12B8A408-3527-4ED5-B964-2701B583FA17Q39186289-E29F09DB-BD9C-46A3-B209-4FBF08395EDBQ41493082-D3A3AA17-EB31-49CD-8D59-4B92EB5D1CCFQ41588248-8E9CD509-041C-4C56-9F38-0CE89E74DEBBQ47917004-E15AB2DC-C636-4097-AD48-27ADAE69AC97Q48659182-345A5307-2094-4865-8332-A4A6FF1CE3FDQ52597543-656E55A1-1495-420D-AEE1-96999202BD4A
P2860
Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Oncogene-targeting T cells rej ...... nts in mouse models of cancer.
@ast
Oncogene-targeting T cells rej ...... nts in mouse models of cancer.
@en
Oncogene-targeting T cells rej ...... nts in mouse models of cancer.
@nl
type
label
Oncogene-targeting T cells rej ...... nts in mouse models of cancer.
@ast
Oncogene-targeting T cells rej ...... nts in mouse models of cancer.
@en
Oncogene-targeting T cells rej ...... nts in mouse models of cancer.
@nl
prefLabel
Oncogene-targeting T cells rej ...... nts in mouse models of cancer.
@ast
Oncogene-targeting T cells rej ...... nts in mouse models of cancer.
@en
Oncogene-targeting T cells rej ...... nts in mouse models of cancer.
@nl
P2093
P2860
P1433
P1476
Oncogene-targeting T cells rej ...... nts in mouse models of cancer.
@en
P2093
Ana Milojkovic
Andreas Herrmann
Christian Buschow
Jehad Charo
Kathleen Anders
Peter Daniel
Thomas Blankenstein
Thomas Kammertoens
P2860
P304
P356
10.1016/J.CCR.2011.10.019
P577
2011-12-01T00:00:00Z